Defining Campylobacter and Immune Response Related Determinants in the Pathogenesis of Guillain-Barré Syndrome Patients in Low-Income Countries
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Defining Campylobacter and Immune Response Related Determinants in the Pathogenesis of Guillain-Barré Syndrome Patients in Low-Income Countries
Principal Institution
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
Principal Investigator(s) (PI)
Islam, Zhahirul
Project Contact Information
Email: zislam@icddrb.org
Year(s) Awarded
2019–2024
Country
Bangladesh
Collaborators
Erasmus University Medical Centre
University of Texas
Washington State University
National Institute of Neurosciences & Hospital
NIH Partners
NINDS
Project Description
This research project will identify potential biomarkers, nutritional factors, and microbial strain differences (using high-throughput sequencing) associated with the response of intravenous immunoglobulin (IVIg) treatment, as well as the clinical course and outcome of Guillain-Barré syndrome (GBS) in low-income countries. The study will improve the understanding of IVIg treatment outcome and provide insight to guide the development of personalized medicine for patients with GBS. The project will involve extensive training activities and guidance from the mentors and training advisory group.
Related World Regions / Countries